Chairman, President & CEO
Dr. Weidong YIN
Independent Director
Mr. Kenneth LEE
Independent Director
Independent Director
Mr. Yuk Lam LO
Independent Director
Mr. Meng MEI


• Dr. Weidong Yin has served as the chairman, president and chief executive officer  of Sinovac Biotech Ltd. since September 2003. Dr. Yin is also the Company’s general manager and secretary as well as the chairman of Sinovac Hong Kong, Tangshan Yian and Sinovac Dalian. Before joining Sinovac, Dr. Yin served as the general manager of Tangshan Yian Bioengineering Co., Ltd. Prior to that, he worked as an infectious disease specialist at the China Center for Disease Control and Prevention inTangshan City, Hebei Province. Dr. Yin has been dedicated to hepatitis research for over 20 years and was instrumental in the development of the Company’s Healive vaccine. In addition, Dr. Yin has been appointed principal investigator by the Chinese Ministry of Science and Technology for many key government R&D programs for vaccines such as inactivated hepatitis A vaccine, inactivated SARS vaccine and H5N1 vaccine. Dr. Yin obtained his MBA from the National University of Singapore and his medical degree from Tangshan Medical School.



• Mr. Kenneth Lee is an independent director of Sinovac. He served on the Company’s Board of Directors since May 2011. In July 2012, the Board appointed  him to the Compensation Committee and Corporate Governance and Nominating Committee as an independent director.  Mr. Lee is a partner at SAIF Partners.  SAIF Partners IV L.P. is currently the largest shareholder in Sinovac.  Mr. Lee has close to 20 years of experience across private equity investment, corporate finance, and business development in China.  Before joining SAIF in 2007, he had served as the chief financial officer of Topsec Holdings from 2006 to 2007.  From 2004 to 2005, he worked as a principal at RimAsia Capital Partners.  Prior to RimAsia Capital Partners, Mr. Lee served in various positions at Delta Associates, the exclusive advisor to Asia Equity Infrastructure Fund,CNK Telecommunications Limited, H&Q Asia Pacific and Salomon Brothers Inc. in New York.  Currently, he is a non-executive director on the boards of four Chinese portfolio companies publicly listed on the stock exchanges in USA and Hong Kong and a board director for four other private Chinese companies backed by SAIF Partners.  Mr. Lee is a graduate of Amherst College.



• Mr. Simon Anderson has served as an independent director of Sinovac since July 2004. Mr. Anderson is the chair the Audit Committee, and a member of the Compensation, and Corporate Governance and Nominating Committees. Mr. Anderson provides consulting expertise in the areas of regulatory compliance, exchange listings and financial operations. He was admitted as a member of the Institute of Chartered Accountants in British Columbia in 1986. Mr. Anderson serves as chief financial officer of companies listed on North American stock exchanges, including IBC Advanced Alloys Corp., which manufactures and processes alloys at its U.S. plants. Mr. Anderson also serves as a director of Simba Gold Corp., a gold exploration company and War Eagle Mining Company Inc., a zinc exploration company. 


• Mr. Yuk Lam Lo  has served as an independent director of Sinovac since March 2006. Mr. Lo is the chair of the Corporate Governance and Nominating Committee and a member of the Audit and Compensation Committees. Mr. Lo has been heavily involved in several committees of the HKSAR Government. He was appointed director of the Hong Kong Applied R&D Fund Co. Ltd., chairman of the Biotechnology Committee of the Hong Kong Industry & Technology Development Council, and chairman of Biotechnology Projects Vetting Committee of the Innovation and Technology Fund. Currently Mr. Lo is serving as a member of the Advisory Council for Food Safety for the Food and Health Bureau, a director of the Chinese Manufacturers’ Association of Hong Kong (CMA) and chairman of the Innovation and Technology Committee of CMA. Mr. Lo is also the honorary founding chairman of Hong Kong Bio-Organization. Additionally, Mr. Lo has been elected an honorary fellow of the Hong Kong University of Science and Technology. He is a member of the Advisory Committee of the Vocational Training Council, an executive vice-president of the Asian College of Management, adjunct professor of the Chinese University of Hong Kong and honorary professor of several universities in China. In China, Mr. Lo was a consultant to the Economic Bureau of Changchun and a member of the Advisory Committee of the Shenzhen Municipal Science and Technology Bureau. At present, he is a consultant for the Centre for Disease Control and Prevention of China. Mr. Lo has almost 30 years of experience as Asia Pacific regional president for two multi-national technology companies, Bio-Rad (NYSE:BIO) and Perkin Elmer (NYSE:PKI), and is currently now the chairman of Lo’s Associates Ltd., vice-chairman of Santai Eco-Fishery Ltd., vice-chairman of APlus OTC Health Group Ltd., senior advisor to Questmark Capital Management Sdn. Bhd., and Senior Director of Questmark Asia Ltd. Mr. Lo is also an independent director of South East Group Ltd. (0726.HK) and Shangpharma (NYSE:SHP).




• Mr. Mei Meng has served as an independent director of Sinovac since March 2012. Mr. Mei is the chairman of Compensation Committee, and a member of the Audit, and Corporate Governance and Nominating Committees. Mr. Mei founded TusPark, a science park established by Tsinghua University in 1994, to incubate high growth companies. He has been the director of TusPark’s Development Center since its inception. Mr. Mei is also the chairman of TusPark Co., Ltd., which is engaged in the development, construction, and management of TusPark and provides services to enterprises based there. TusPark is also involved in venture capital investments in China. Mr. Mei sits on the expert panel for China’s National Science & Technology Award. He has developed courses on entrepreneurship and new venture formation as a Tsinghua University professor and an entrepreneur. Mr. Mei holds a bachelor’s degree in Automation from Tsinghua University.

Copyright © 2001-2015 Sinovac Biotech Ltd. All Rights Reserved.

Add: No. 39 Shangdi Xi Road, Haidian District, Beijing, P.R.C. 100085 Supported by elongtian